Clinical Trials

Simpson Interventions announced today that investigators completed the first cases in a trial of its Acolyte catheter system. The Acolyte study, a pivotal investigational device...

Fractyl Health announced new data supporting its Revita procedure and priced a new public offering. The data came from the company’s Germany Real-world Registry. It...

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The...

Xvivo announced it enrolled the first patient as part of a continued access protocol (CAP) study for its Heart Assist Transport system. The CAP study...

Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces encouraging preliminary data for Xabg,...

The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Dymicron to initiate a pivotal trial of its Triadyme-C...

Radical Catheter Technologies™, a pioneering medical device company and a NeuroTechnology Investors (NTI) portfolio company focused on advancing the next generation of endovascular access...

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The Phase Ib study (NCT06673017)...

InterShunt Technologies announced it began an early feasibility study of its device for reducing heart failure symptoms. Dr. Sitaramesh Emani and the Structural Heart Intervention...